Saving Lives.
Improving Sepsis Care.

Sepsiscan solution is a bedside hyperspectral imaging device for real-time evaluation of the microcirculation function of patients within ICUs and EDs.

problem

Sepsis affects 49 million people worldwide

Sepsis is a major global health concern affecting around 48.9 million people every year. It is a life-threatening syndrome of organ dysfunction caused by an inadequate immune system response to infection.

Sepsis kills 11 million people worldwide

Despite declining age-standardized incidence and mortality, sepsis remains a major cause of health loss worldwide. 11 million sepsis-related deaths were reported, representing 19.7% of all global deaths.

36 000 EUR TO TREAT EACH SEPSIS PATIENT IN ICU

The median total sepsis costs per country are approximately €36 000, which equals €50 per capita annually. Time-critical initiatives for sepsis prevention are required to reduce this.

Source: Rudd et al. (2020). Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. The Lancet, vol. 395 (10219), pp.200-211.

CHALLENGES IN SEPSIS TREATMENT

According to the World Health Assembly, “while sepsis itself cannot always be predicted, its ill effects in terms of mortality and long-term morbidity can be mitigated through early diagnosis and appropriate and timely clinical management”.

Improving early recognition, diagnosis, and treatment of sepsis is critical in reducing its impact on public health and saving lives worldwide.

The most effective means to combat infection and reverse life-threatening organ dysfunction caused by sepsis is rapid diagnosis and immediate treatment and resuscitation.

Vision

Provide bedside hyperspectral imaging devices for doctors worldwide, that help identify patients at high risk of sepsis complications early on and monitor their response to treatment more effectively.

The solution will lead to more timely interventions and better outcomes for patients with sepsis.